Skip to main content
STRATA Skin Sciences, Inc. logo

STRATA Skin Sciences, Inc. — Investor Relations & Filings

Ticker · SSKN ISIN · US86272A2069 LEI · 529900JXBTG5OB59PM04 US Manufacturing
Filings indexed 999 across all filing types
Latest filing 2020-11-27 Proxy Solicitation & In…
Country US United States of America
Listing US SSKN

About STRATA Skin Sciences, Inc.

https://www.strataskinsciences.com/

STRATA Skin Sciences, Inc. is a medical technology company that develops, commercializes, and markets products for the in-office treatment of dermatological conditions. The company's portfolio is designed to provide solutions for chronic skin diseases and aesthetic concerns. Key products include the XTRAC® excimer laser and the VTRAC® excimer lamp system, which are used to treat psoriasis, vitiligo, leukoderma, and atopic dermatitis by delivering targeted therapeutic light. STRATA also offers the TheraclearX® system for the treatment of acne. The company provides its devices and services directly to dermatologists' offices, often employing a recurring revenue business model based on procedural usage.

Recent filings

Filing Released Lang Actions
DEF 14A
Proxy Solicitation & Information Statement
2020-11-27 English
PRE 14A
Regulatory Filings
2020-11-17 English
FORM 4 FOR MATTHEW HILL DATED 11-13-2020
Director's Dealing
2020-11-13 English
STRATA 8-K FOR UPDATED INVESTOR PRESENTATION
Regulatory Filings
2020-11-12 English
STRATA 3RD QUARTER 10Q, 2020
Interim / Quarterly Report Q3 2020
2020-11-10 English
8-K FOR THE THIRD QUARTER 2020 EARNINGS PRESS RELEASE, DATED NOVEMBER 10, 2020.
Regulatory Filings
2020-11-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.